ENOV 46.67 Stock Price Enovis Corporation
Range: | 38.27-65.03 | Vol Avg: | 645176 | Last Div: | 0 | Changes: | 0.5 |
Beta: | 2 | Cap: | 2.61B | Currency: | USD | Exchange: | NYSE |
Sector: | Industrials | IPO: | Thu May 08 2008 | Empoloyees: | 6550 |
CUSIP: | 194014502 | CIK: | 0001420800 | ISIN: | US1940145022 | Country: | US |
CEO: | Mr. Matthew L. Trerotola | Website: | https://www.enovis.com |
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.